Literature DB >> 26771870

Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices.

Kai MacDonald1,2, Kristy Lamb1,2,3, Michael L Thomas1, Wendy Khentigan4.   

Abstract

BACKGROUND: Despite the existence of evidence-based guidelines, different prescriber practices around buprenorphine maintenance treatment (BMT) of opiate dependence exist. Moreover, certain prescriber beliefs may influence their practice patterns.
OBJECTIVE: To understand community BMT practice patterns and discern their relationship to practitioner beliefs.
METHOD: Survey of 30 local BMT prescribers about aspects of BMT, and analysis of correlations between practices and practitioner beliefs.
RESULTS: Practitioners generally followed standard treatment guidelines, though the most-common maintenance dosages of BMT (4-12 mg) were lower than recommended by some studies. Endorsement of belief in a "spiritual basis" of addiction correlated with lower average BMT doses and less frequent endorsement of the belief that BMT-treated patients are "in recovery." CONCLUSIONS/IMPORTANCE: These data suggest that relatively standardized, longer-term BMT of opiate dependence is accepted among the majority of surveyed prescribers, and certain provider beliefs about addiction may influence prescribing habits and attitudes. Future studies should: (1) assess these findings in larger samples; (2) examine how prescriber beliefs about addiction and BMT compare with those of other addiction treatment providers; and (3) ascertain whether individual prescriber beliefs influence patient outcomes.

Entities:  

Keywords:  Opiate dependence; buprenorphine; psychopharmacology; stigma

Mesh:

Substances:

Year:  2016        PMID: 26771870     DOI: 10.3109/10826084.2015.1089905

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  5 in total

Review 1.  Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Authors:  Rebecca L Haffajee; Cecelia A French
Journal:  Curr Opin Psychol       Date:  2019-02-04

Review 2.  Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.

Authors:  Bertha K Madras; N Jia Ahmad; Jenny Wen; Joshua Sharfstein Sharfstein
Journal:  NAM Perspect       Date:  2020-04-27

3.  Preliminary attitudes on medications for opioid use disorders (MOUDs) in Southeastern Switzerland and New York City.

Authors:  Felipe Castillo; Daniel Scalise; David Hernandez; Rahul Gupta; Cale N Basaraba; Thomas Corbeil; Sandra D Comer; Andres R Schneeberger
Journal:  J Addict Dis       Date:  2022-04-22

4.  Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.

Authors:  Kirsten E Smith; Martha D Tillson; Michele Staton; Erin M Winston
Journal:  Drug Alcohol Depend       Date:  2020-01-09       Impact factor: 4.492

5.  US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress.

Authors:  Hannah K Knudsen; Michelle R Lofwall; Lewei Allison Lin; Sharon L Walsh; Jamie L Studts
Journal:  Drug Alcohol Depend       Date:  2019-08-30       Impact factor: 4.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.